Загрузка...
Trial by CCN2: a standardized test for fibroproliferative disease?
A major issue concerning clinical trials is the availability of standardized assays to evaluate drug efficacy. Ideally, such assays should test the effect of a putative drug on the expression of a biomarker in biological fluids. In a recent study by Kuiper et al. (PLOS One, 3(7): e2675). The relativ...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Netherlands
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686749/ https://ncbi.nlm.nih.gov/pubmed/19266315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-009-0041-y |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|